NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3408962 Query DataSets for GSM3408962
Status Public on Jul 22, 2019
Title BRD4_ChIPSeq_IBET151_5000nM_MV4;11_rep1
Sample type SRA
 
Source name AML cells
Organism Homo sapiens
Characteristics cell type: Biphenotypic B Myelomonocytic Leukemia
chip antibody: BRD4 (Bethyl labs #A301-985A)
Treatment protocol Cells were seeded at 5000 cells/well in 96well plates, 1ul of I-BET151 was added per well from 100x DMSO stocks (final DMSO concentration: 1%) and cells were incubated for 72hrs. Cell viability was measured using Cell TiterGlo assay kit (Promega) following manufacturer instructions
Cells were seeded at 5000 cells/well in 96well plates, 1ul of I-BET151 was added per well from 100x DMSO stocks (final DMSO concentration: 1%) and cells were incubated for 72hrs. Cell viability was measured using Cell TiterGlo assay kit (Promega) following manufacturer instructions
Growth protocol MV4;11 and K562 cells were grown in RPMI-1640 supplemented with 10% FBS, in a humidified incubator (37 °C, 5% CO2).
MV4;11 and K562 cells were grown in RPMI-1640 supplemented with 10% FBS, in a humidified incubator (37 °C, 5% CO2).
Extracted molecule genomic DNA
Extraction protocol K562 and MV4;11 cells were treated with either DMSO or increasing concentration of I-BET151 for 6 hours at 37C. After treatment, cells were cross-linked with 1% formaldehyde for 10 min at room temperature, and cross-linking was stopped by the addition of 0.125 M glycine. Cells were then lysed using the SimpleChIP® Enzymatic Chromatin IP Kit (CST #9004) and DNA was digested to mostly mononucleosomes as recommended by the manufacturer
Library preparation of immunoprecipitated DNA was done using the NEBNext® ChIPSeq Library Prep Master Mix Set for Illumina® (NEB) and samples were sequenced in a 50bp single end run on the Illumina HiSeq-2000
K562 and MV4;11 cells were treated with either DMSO or increasing concentration of I-BET151 for 6 hours at 37C. After treatment, cells were cross-linked with 1% formaldehyde for 10 min at room temperature, and cross-linking was stopped by the addition of 0.125 M glycine. Cells were then lysed using the SimpleChIP® Enzymatic Chromatin IP Kit (CST #9004) and DNA was digested to mostly mononucleosomes as recommended by the manufacturer
Library preparation of immunoprecipitated DNA was done using the NEBNext® ChIPSeq Library Prep Master Mix Set for Illumina® (NEB) and samples were sequenced in a 50bp single end run on the Illumina HiSeq-2000
 
Library strategy ChIP-Seq
Library source genomic
Library selection ChIP
Instrument model Illumina HiSeq 2000
 
Description BRD4_MV411_ChIP_BRD4_151_C_5000nM_RPGC_inputSub.bw
MV411_ChIP_BRD4_151_C_5000nM.bed
Data processing Quality check for raw sequencing reads was performed using FastQC
ChIP-seq and Chem-seq reads were aligned to the hg19 genome assembly using bwa with default parameters
Data were filtered for duplicated reads using samtools
Peaks were called using a MACS2 derived pipeline on two replicates for each sample using a combination of lenient and strick p-value largely inspired by the IDR workflow.
Bigwig profiles were created using deeptools normalized using the RPGC method with input subtracted
Genome_build: hg19
Supplementary_files_format_and_content: processed data files include signal files (biwig) and peak files (bed)
 
Submission date Oct 01, 2018
Last update date Jul 22, 2019
Contact name Pierre Khoueiry
Organization name American University of Beirut
Department Biochemistry and Molecular Genetics
Street address Bliss street
City Beirut
ZIP/Postal code 11-0236
Country Lebanon
 
Platform ID GPL11154
Series (1)
GSE120715 Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity
Relations
BioSample SAMN10150462
SRA SRX4781511

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap